Click here to visit our General Public Section

 

What is C-Reactive Protein (CRP) ? - Guidelines - Clinical Trials - Discussion Forum - Editorial Board - Supporter - About
Search for: Your source on hs-CRP testing
Your source on hs-CRP testing  Sign In      Register Now!
Online Presentations
Browse by:     topic   |   date  |   speaker  |   accredited presentations  |   podcast  

Aspirin and Statins in RA - The evidence
Dr. Eswar Krishnan - Biography
English - 2009-06-16
Speaker Disclosure
- E. Krishnan: Received grant support from and is a consultant for Takeda Pharmaceuticals North America, Inc.
- Shareholder and Advisory Board, Savient Pharmaceuticals, Inc.
- This talk does not discuss any commercial products of these companies
- This talk discusses off-label use of aspirin and statin medications
You are in the process of obtaining Credit(s)™ for this presentation.
Please follow the blinking red arrow, which indicates the next step towards obtaining credit.
Last time viewed : 


Slides not yet viewed :
Presentation about C-Reactive Protein - Last time viewed : 


Slides not yet viewed :
Last time viewed : 


Slides not yet viewed :

Summary

Rheumatoid arthritis (RA) is an inflammatory condition, known to be associated with increased risk for coronary artery disease (CAD). Aspirin and statins are among the most effective treatments for preventing and/or treating coronary artery disease, says Dr. Krishnan. Do they also mitigate the increased risk in patients with RA?

Two prospective studies were reported in the 1970s, from the Mayo Clinic and the Rheumatism Foundation Hospital in Finland, which looked at aspirin use and cardiovascular outcomes in patients with RA. The first study showed a non-significant benefit in men; and the doses used in the majority of patients in this study were higher, over a gram per day. The Finnish study showed no relationship between myocardial infarction and aspirin use in RA.

A randomized double-blind crossover study from Cambridge, UK, (Mäki-Petäjä KM et al. JACC 2007), looked at surrogate cardiovascular endpoints in RA patients taking ezetimibe or simvastatin. These results suggested that the medications may have anti-inflammatory effects and may improve vascular function in RA.

Copyright © 2009 MULTIWEBCAST "State-of-the-Art Webcast Services"


Learning objectives

After viewing this presentation the participant will be able to:
- Identify the potential relationship between aspirin use, statin use and coronary artery disease risk among patients with rheumatoid arthritis


Bibliographic references

Isomaki, H. A. Aspirin and Myocardial Infarction In Patients With Rheumatoid Arthritis. The Lancet. 1972 Oct 300(7781):831.

Kurth T, Hennekens CH, Buring JE, Gaziano JM. Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis. Curr Rheumatol Rep. 2004 Oct;6(5):351-6.

Lévy L, Fautrel B, Barnetche T, Schaeverbeke T. Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol. 2008 Jul-Aug;26(4):673-9.

Linos A, Worthington JW, O'Fallon W, Fuster V, Whisnant JP, Kurland LT. Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. A long-term follow-up study. Mayo Clin Proc. 1978 Sep;53(9):581-6.

Mäki-Petäjä KM, Booth AD, Hall FC, Wallace SM, Brown J, McEniery CM, Wilkinson IB. Ezetimibe and Simvastatin Reduce Inflammation, Disease Activity, and Aortic Stiffness and Improve Endothelial Function in Rheumatoid Arthritis. J Am Coll Cardiol. 2007 Aug 28;50(9):852-8.

Wolfe F, Michaud K.The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis. Arthritis Rheum. 2008 Sep;58(9):2612-21.


 Your source on CRP information
CRPhealth.com is owned by E-MedHosting.com Inc. Last update: 2012-01-26
Copyright © 2000-2012 E-MedHosting.com inc. All rights reserved.
Disclaimer  |  Sponsors' Disclaimer  |  Help / Contact us